Aripiprazol EQL Pharma approved
The pharmaceutical Aripiprazole EQL Pharma, oral solution 1mg / ml, has been approved by the Swedish Medicines Agency for sale.Aripiprazole EQL Pharma is a prescription drug used to treat schizophrenia in adults and adolescents from the age of 15 years. Aripiprazole EQL Pharma is also used to treat moderate to severe manic episodes in bipolar disorder. Aripiprazole EQL Pharma contains aripiprazole, a substance that has been registered as an oral solution in Sweden since 2005. The market for aripiprazole oral solution is limited to approximately SEK 2 million in total annual sales in